p27 Deficiency and Bcl-2 in T-Cell Lymphoma
Author Information
Author(s): Cheng Ningli, van de Wetering Christopher, Knudson C. Michael, Klefstrom Juha
Primary Institution: University of Iowa Roy J. and Lucille P. Carver College of Medicine
Hypothesis
p27 may suppress tumor formation by Bcl-2 family members.
Conclusion
p27 deficiency significantly accelerates T cell lymphoma development when combined with Bcl-2 expression.
Supporting Evidence
- p27 deficiency synergistically cooperates with Bcl-2 to increase T cell hyperplasia.
- Over 90% of p27 deficient Lck-Bcl-2 mice developed thymic T cell lymphomas within one year.
- Bcl-2 retains its anti-proliferative function even in the absence of p27.
Takeaway
This study shows that a lack of a protein called p27, when combined with another protein called Bcl-2, can lead to a fast-growing type of cancer in T cells.
Methodology
The study involved crossing p27 deficient mice with Lck-Bcl-2 transgenic mice to assess lymphoma development and T cell proliferation.
Limitations
The study primarily focuses on specific mouse models, which may not fully represent human conditions.
Participant Demographics
Mice used in the study included Lck-Bcl-2 and p27 deficient transgenic strains.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website